RBOT Market Analysis

Overview

Fundamentals

P/E ratio
EPS (TTM)$-6.620.0% YoY
Profit margin0.0%HEALTHCARE
Market cap$3.5MMicro cap

Valuation

Forward P/E
PEG ratio
P/B
0.94
P/S (TTM)
EV/EBITDA
24.74

Profitability & growth

ROE (TTM)
-177.5%
Operating margin
0.0%
Revenue growth YoY
0.0%
Dividend yield
Beta
1.82
Last earnings
Dec 31, 2025 · Estimate $-1.37 · Reported $-1.65
Analyst estimate. Actual results often differ.

Ratios are point-in-time. Historical metrics — no guarantees about what comes next.

News & Sentiment

Page 1 of 3 · 50 total

Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.

About Vicarious Surgical Inc.

Vicarious Surgical Inc. (RBOT) is a cutting-edge medical technology company revolutionizing surgical practices with its advanced robotic surgical systems designed to enhance precision and improve patient outcomes. By leveraging a proprietary platform that integrates advanced robotics and artificial intelligence, the company is at the forefront of the minimally invasive surgery movement, equipping surgeons with unmatched dexterity, visualization, and control. Vicarious Surgical not only aims to boost surgical efficiency but also to significantly reduce patient recovery times, addressing the…

Classification

Exchange
NYSE
Country
USA
Currency
USD

Company profile

HQ
78 FOURTH AVENUE, WALTHAM, MA
Fiscal year end
December
Latest quarter
Mar 31, 2026
Market cap$3.5M
Shares outstanding$6.5M
52W high$13.75
52W low$0.27

Educational content · Not investment advice or recommendations

We're educators, not advisors. Your decisions are your own. Disclaimer